Harris & Harris Group(NASDAQ:TINY) announced the earnings results for Fiscal Year 2016 and Q4. The results came in during Pre-Market on Mar 17, 2017. Based on the corporate Earnings and Guidance, many Investment Banking firms balance their portfolio to Sell and Buy Stocks based on their strategy of investing in stocks.Earnings per share were $-0.09.
Harris & Harris Group (TINY) shares turned negative on Wednesdays trading session with the shares closing down -0.01 points or -0.76% at a volume of 59,583. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $1.33. The peak price level was also seen at $1.33 while the days lowest was $1.3. Finally the shares closed at $1.31. The 52-week high of the shares is $1.97 while the 52-week low is $1.1828. According to the latest information available, the market cap of the company is $40 M.
Several Insider Transactions has been reported to the SEC. On Jan 11, 2017, Douglas W Jamison (CEO) purchased 2,090 shares at $1.32 per share price.Also, On Dec 29, 2016, Kevin Rendino (director) purchased 40,432 shares at $1.34 per share price.On Dec 28, 2016, Daniel B Wolfe (President) purchased 6,000 shares at $1.30 per share price, according to the Form-4 filing with the securities and exchange commission.
Harris & Harris Group Inc. is a venture capital firm. The Firm is regulated as a business development company. Its investment objective is to achieve long-term capital appreciation by making venture capital investments. As a venture capital firm it invests in and provides managerial assistance to its portfolio companies. The Firm’s investment has two characteristics: early stage where its focus is on founding incubating and building transformative companies from disruptive science and BIOLOGY+ investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics physics materials science chemistry information technology engineering and mathematics.